CRYSTAL MONTAGUE: Open Payments
NPI 1669887774 · HIGH POINT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,067 in 110 payments from 21 companies in 2025. Trend: 2023 $2,172 · 2024 $2,359 · 2025 $2,067
Food & beverage: $2,067
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 11 | $339 |
| Otsuka America Pharmaceutical, Inc. | 14 | $200 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $192 |
| Supernus Pharmaceuticals, Inc. | 10 | $173 |
| Teva Pharmaceuticals USA, Inc. | 14 | $159 |
| ABBVIE INC. | 10 | $158 |
| Alkermes, Inc. | 9 | $141 |
| E.R. Squibb & Sons, L.L.C. | 5 | $118 |
| Axsome Therapeutics, Inc. | 5 | $103 |
| Lundbeck LLC | 3 | $91 |
Products named: INVEGA SUSTENNA, REXULTI, CAPLYTA, Qelbree, VRAYLAR, ARISTADA, COBENFY, Auvelity.
Industry payments across NC — which companies pay providers there.
